Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?Bortezomib market france?Novartis patent term dabrafenib?Dabrafenib btd date 2023?When will tenofovir alafenide come off patent in canada?
See the DrugPatentWatch profile for Efinaconazole
Efinaconazole is available in India under the brand name Jublia. Jublia is manufactured by Dr. Reddy's Laboratories [1].
Jublia is a topical antifungal medication prescribed for the treatment of onychomycosis, a fungal infection of the nail [1].
Efinaconazole belongs to a class of drugs called azole antifungals. It works by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for the synthesis of ergosterol in fungal cell membranes. By disrupting ergosterol production, efinaconazole weakens the fungal cell membrane, leading to cell death [2].
Information regarding specific patent expiry dates for Jublia in India is not readily available. Patent details and their expiry timelines are often complex and can vary based on patent filings and legal challenges. Resources like DrugPatentWatch.com can provide detailed patent information for pharmaceutical products [3].
Other Questions About Efinaconazole :